• Dual Immunoglobulin, Aimovig Therapies Safe for MG, Migraines, Report Says
  • Fighting to Live During a Nationwide COVID-19 Lockdown
  • Increasing Expenses for MG Patients In China Suggest Inadequacy of Current Medical Insurance Policies, Study Says
  • Levels of Certain B- and T-cells Linked to Ocular MG Turning Generalized
  • Let’s Work Together to Stay Safe During the Coronavirus Crisis
  • Osteopontin Protein May Worsen MG by Affecting Immune Cells, Study Finds
  • Complete MG Remission Seen as More Likely in Robot-assisted Thymectomy
  • Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare
  • Expressing Gratitude: Being ‘Rare’ Has Positive Attributes, Too
  • HBM9161 Shows Potential to Treat Autoimmune Diseases, Early Data Suggest
  • Elsevier Opens Books, Review Articles to Rare Disease Researchers Starting Feb. 29
  • Advice on Starting Nonprofit Groups for Rare and Other Diseases Focus of NORD Webinar